BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24334115)

  • 21. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
    Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
    Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
    [No Abstract]   [Full Text] [Related]  

  • 22. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.
    Ehsani M; Imani A; Moravveji A
    Mol Biol Rep; 2018 Aug; 45(4):621-624. PubMed ID: 29855758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.
    Brandimarti F; Alessandrini F; Pesaresi M; Catalani C; De Angelis L; Galeazzi R; Giovagnetti S; Gesuita R; Righi E; Giorgetti R; Tagliabracci A
    Int J Legal Med; 2017 Mar; 131(2):447-458. PubMed ID: 27933413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent thrombembolic risk in patients with multiple thrombophilic disorders.
    Agoşton-Coldea L; Rusu LD; Bobar C; Rusu ML; Mocan T; Procopciuc LM
    Rom J Intern Med; 2008; 46(3):261-6. PubMed ID: 19366087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.
    Bezgin T; Kaymaz C; Akbal Ö; Yılmaz F; Tokgöz HC; Özdemir N
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):100-106. PubMed ID: 27729560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis].
    Kapustin SI; Blinov MN; Kargin VD; Filanovskaia LI; Saltykova NB; Beliazo OE; Golovina OG; Shmeleva VM; Panshina AM; Papaian LP
    Ter Arkh; 2003; 75(10):78-80. PubMed ID: 14669613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences.
    Ivanov P; Komsa-Penkova R; Kovacheva K; Ivanov Y; Stoyanova A; Ivanov I; Pavlov P; Glogovska P; Nojarov V
    Lung; 2008; 186(1):27-36. PubMed ID: 18097719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
    Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
    Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
    [No Abstract]   [Full Text] [Related]  

  • 35. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia.
    Bedencic M; Bozic M; Peternel P; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):58-63. PubMed ID: 19127083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
    Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
    Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.
    Meglic L; Stegnar M; Milanez T; Bozic M; Peterlin B; Peternel P; Novak-Antolic Z
    Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):157-63. PubMed ID: 14597244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
    Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.